4.00
4.00 (0%)
As of Feb 14, 2025
Vivos Therapeutics, Inc. [VVOS]
Source:
Company Overview
Vivos Therapeutics, Inc. is a revenue stage medical technology company focused on the development and commercialization of a suite of innovative diagnostic andmulti-disciplinary treatment modalities for patients with cranial, dentofacial and postural abnormalities and the wide array of medicalconditions that may result from them, including mild to severe obstructive sleep apnea (known as OSA) and snoring in adults and childrenages.
| Country | United States |
| Headquarters | littleton, colorado |
| Phone Number | (866)908-4867 |
| Industry | manufacturing |
| CEO | R. Kirk Huntsman |
| Website | vivos.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $15 |
| Operating Profit | $-11.2 |
| Net Income | $-11.1 |
| Net Cash | $4.6 |
Profit Ratios
| Gross Margin | $9 |
| Operating Margin | -74.3 |
| Profit as % of Revenues | -81% |
| Profit as % of Assets | -85.6% |
| Profit as % of Stockholder Equity | -140% |
Management Effectiveness
| Return on Equity | -140% |
| Return on Assets | -72.9% |
| Turnover Ratio | 115.6% |
| EBITA | $-10.6 |
Balance Sheet and Cash Flow Measures
| Total Assets | $15.3 |
| Total Liabilities | $7.3 |
| Operating Cash Flow | $-12.7 |
| Investing Cash Flow | $-0.6 |
| Financing Cash Flow | $17.9 |
